The quest for genes causing complex traits in ocular medicine: Successes, interpretations, and challenges

Archives of Ophthalmology

Volumn 125, Issue 1, 2007, Pages 11-18

  Iyengar, Sudha K ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H;

CHROMOSOME 10Q; CHROMOSOME 14Q; CHROMOSOME 1Q; CHROMOSOME 5Q; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; EYE DISEASE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; GLAUCOMA; HUMAN; HUMAN GENOME PROJECT; INTRAOCULAR PRESSURE; LINKAGE ANALYSIS; MEDICAL RESEARCH; MEDICAL SPECIALIST; META ANALYSIS; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

CHROMOSOME MAPPING; EYE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); QUANTITATIVE TRAIT, HERITABLE;

EID: 33846069632     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.1.11     Document Type: Review

References (101)

1. Elston RC, Rao DC. Statistical modeling and analysis in human genetics. Annu Rev Biophys Bioeng. 1978;7:253-286.
2. Bailer AJ, Piegorsch WW. Estimating integrals using quadrature methods with an application in pharmacokinetics. Biometrics. 1990;46:1201-1211.
3. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
4. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291:1304-1351.
5. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426:789-796.
6. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat Rev Genet. 2004;5:467-475.
7. Risch N. Linkage strategies for genetically complex traits, I: multilocus models. Am J Hum Genet. 1990;46:222-228.
8. James JW. Frequency in relatives for an all-ornone trait. Ann Hum Genet. 1971;35:47-49.
9. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38:1055-1059.
10. Guo SW. Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet. 1998;63:252-258.
11. Elston RC. 'Twixt cup and lip: how intractable is the ascertainment problem? Am J Hum Genet. 1995;56:15-17.
12. Duggirala R, Williams JT, Williams-Blangero S, Blangero J. A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol. 1997;14:987-992.
13. Strachan T, Read AP. Human Molecular Genetics 2. 2nd ed. New York, NY: Garland Science; 1999.
14. Thomas DC. Statistical Methods in Genetic Epidemiology. New York, NY: Oxford University Press; 2004.
15. Wiggs JL. Genes associated with human glaucoma. Ophthalmol Clin North Am. 2005;18:335-343.
16. Francis PJ. Genetics of inherited retinal disease. J R Soc Med. 2006;99:189-191.
17. Kelly J, Maumenee IH. Hereditary macular diseases. Int Ophthalmol Clin. 1999;39:83-115.
18. Chung M, Lotery AJ. Genetics update of macular diseases. Ophthalmol Clin North Am. 2002;15:459-465.
19. Hewitt AW, Craig JE, Mackey DA. Complex genetics of complex traits: the case of primary open-angle glaucoma. Clin Experiment Ophthalmol. 2006;34:472-484.
20. Libby RT, Gould DB, Anderson MG, John SW. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet. 2005;6:15-44.
21. Morton NE. Genetic tests under incomplete ascertainment. Am J Hum Genet. 1959;11:1-16.
22. Elston RC. The genetic dissection of multifactorial traits. Clin Exp Allergy. 1995;25(suppl 2):103-106.
23. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972;2:3-19.
24. Brown DL, Gorin MB, Weeks DE. Efficient strategies for genomic searching using the affected-pedigree-member method of linkage analysis. Am J Hum Genet. 1994;54:544-552.
25. Goldgar DE. Multipoint analysis of human quantitative genetic variation. Am J Hum Genet. 1990;47:957-967.
26. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535-543.
27. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
28. Abecasis GR, Yashar BM, Zhao Y, et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet. 2004;74:482-494.
29. Schick JH, Iyengar SK, Klein BE, et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet. 2003;72:1412-1424.
30. Iyengar SK, Song D, Klein BE, et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet. 2004;74:20-39.
31. Majewski J, Schultz DW, Weleber RG, et al. Age-related macular degeneration - a genome scan in extended families. Am J Hum Genet. 2003;73:540-550.
32. Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet. 2003;73:780-790.
33. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet. 2004;75:174-189.
34. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: an expanded genomewide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol. 2001;132:682-692.
35. Weeks DE, Conley YP, Mah TS, et al. A full genome scan for age-related maculopathy. Hum Mol Genet. 2000;9:1329-1349.
36. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet. 2005;14:2257-2264.
37. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996;58:1347-1363.
38. Shastry BS, Hartzer MK, Trese MT. Familial exudative vitreoretinopathy: multiple modes of inheritance. Clin Genet. 1993;44:275-276.
39. Young TL. Ophthalmic genetics/inherited eye disease. Curr Opin Ophthalmol. 2003;14:296-303.
40. MacDonald IM, Sasi R. Molecular genetics of inherited eye disorders. Clin Invest Med. 1994;17:474-498.
41. Cremers FP, van den Hurk JA, den Hollander AI. Molecular genetics of Leber congenital amaurosis. Hum Mol Genet. 2002;11:1169-1176.
42. Genetic eye diseases: retinitis pigmentosa and other inherited eye disorders. Proceedings of the International Symposium on Genetics and Ophthalmology, held in Jerusalem, Israel, September 1981. Birth Defects Orig Artic Ser. 1982;18(6):1-746.
43. Center for Inherited Disease Research Web site. http://www.cidr.jhmi.edu/ .
44. Peacock E, Whiteley P. Perlegen Sciences, Inc. Pharmacogenomics. 2005;6:439-442.
45. Padhukasahasram B, Wall J, Marjoram P, Nordborg M. Estimating recombination rates from SNPs using summary statistics. Genetics. September 15, 2006:[Epub ahead of print].
46. Sheffield VC, Carmi R, Kwitek-Black A, et al. Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum Mol Genet. 1994;3:1331-1335.
47. Hastbacka J, de la CA, Kaitila I, Sistonen P, Weaver A, Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet. 1992;2:204-211.
48. Houwen RH, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet. 1994;8:380-386.
49. Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science. 1987;236:1567-1570.
50. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
51. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration: clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116:1082-1088.
52. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
53. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227-3236.
54. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005;77:389-407.
55. Fisher R. The correlation between relatives on the supposition of Mendelian in heritance. Trans R Soc Edinburgh. 1918;(52):399-433.
56. Rotimi CN, Chen G, Adeyemo AA, et al. Genomewide scan and fine mapping of quantitative trait loci for intraocular pressure on 5q and 14q in West Africans. Invest Ophthalmol Vis Sci. 2006;47:3262-3267.
57. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet. 2001;68:1197-1206.
58. Olson JM. A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet. 1999;65:1760-1769.
59. Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, Boehnke M. Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol. 2004;27:53-63.
60. Schaid DJ, Olson JM, Gauderman WJ, Elston RC. Regression models for linkage: issues of traits, covariates, heterogeneity, and interaction. Hum Hered. 2003;55:86-96.
61. Strachan T, Read AP. Human Molecular Genetics 3. Oxford, England: Garland Science/Taylor & Francis Group; 2003.
62. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet. 1995;57:455-464.
63. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506-516.
64. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet. 1998;62:450-458.
65. Tang S, Toda Y, Kashiwagi K, et al. The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene. Hum Genet. 2003;113:276-279.
66. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077-1079.
67. Wiggs JL, Allingham RR, Vollrath D, et al. Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet. 1998;63:1549-1552.
68. Fingert JH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899-905.
69. Colomb E, Nguyen TD, Bechetoille A, et al. Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open-angle glaucoma. Clin Genet. 2001;60:220-225.
70. Baird PN, Craig JE, Richardson AJ, et al. Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder effect for the Q368STOP mutation of myocilin. Hum Genet. 2003;112:110-116.
71. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet. 1997;6:2091-2097.
72. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338:1022-1027.
73. Evans DM, Cardon LR. Genome-wide association: a promising start to a long race. Trends Genet. 2006;22:350-354.
74. Lawrence RW, Evans DM, Cardon LR. Prospects and pitfalls in whole genome association studies. Philos Trans R Soc Lond B Biol Sci. 2005;360:1589-1595.
75. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet. 2005;366:1223-1234.
76. Zeggini E, Rayner W, Morris AP, et al. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat Genet. 2005;37:1320-1322.
77. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet. 2004;5:89-100.
78. Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
79. Lin S, Chakravarti A, Cutler DJ. Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nat Genet. 2004;36:1181-1188.
80. Lin S, Chakravarti A, Cutler DJ. Haplotype and missing data inference in nuclear families. Genome Res. 2004;14:1624-1632.
81. Lin S, Cutler DJ, Zwick ME, Chakravarti A. Haplotype inference in random population samples. Am J Hum Genet. 2002;71:1129-1137.
82. Shen R, Fan JB, Campbell D, et al. Highthroughput SNP genotyping on universal bead arrays. Mutat Res. 2005;573:70-82.
83. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques. June 2002 (suppl):5658, 60-61.
84. Gunderson KL, Kruglyak S, Graige MS, et al. Decoding randomly ordered DNA arrays. Genome Res. 2004;14:870-877.
85. Gunderson KL, Steemers FJ, Ren H, et al. Whole-genome genotyping. Methods Enzymol. 2006;410:359-376.
86. Fan JB, Yeakley JM, Bibikova M, et al. A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res. 2004;14:878-885.
87. Fan JB, Oliphant A, Shen R, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol. 2003;68:69-78.
88. Lipshutz RJ, Taverner F, Hennessy K, Hartzell G, Davis R. DNA sequence confidence estimation. Genomics. 1994;19:417-424.
89. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675-1680.
90. Chee M, Yang R, Hubbell E, et al. Accessing genetic information with high-density DNA arrays. Science. 1996;274:610-614.
91. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet. 1999;65:220-228.
92. Pritchard JK, Donnelly P. Case-control studies of association in structured or admixed populations. Theor Popul Biol. 2001;60:227-237.
93. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55:997-1004.
94. Kuehn BM. NIH initiatives to probe contribution of genes, environment in disease. JAMA. 2006;295:1633-1634.
95. Wilson SH, Olden K. The environmental genome project: phase I and beyond. Mol Interv. 2004;4:147-156.
96. Wright AF, Hastie ND. Complex genetic diseases: controversy over the Croesus code. Genome Biol. 2001;2(8):comment 2007.
97. Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension. 2002;39:323-331.
98. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 2001;69:124-137.
99. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812-820.
100. Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995;57:289-300.
101. Tsuchiya T, Schwarz PE, Bosque-Plata LD, et al. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab. 2006;89:174-184.